Abstract
Paroxysmal Nocturnal Haemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder caused by PIG-A gene alterations. In contrast to the growing knowledge regarding the pathophysiology of the disease, data on factors influencing survival are scarce, mainly as a result of the rarity of the disease. Data on 220 patients, diagnosed with PNH over a 46-year period in reporting French centers, were collected. Kaplan-Meier survival estimates (mean +/− standard error) were 65±4% and 48±6% at 10 and 15 years after diagnosis, respectively. In this cohort of 220 patients with PNH, aplastic anemia (AA) antedated PNH in 65 patients with a median interval of 3.1 years. These 65 patients with an AA-PNH syndrome were shown to have a relative risk (RR) of death 3 times lower than the remaining 155 patients with de novo PNH. Finding a better prognosis among patients with AA before diagnosis of PNH might be surprising, we thus reassessed, the differences between the AA-PNH syndrome and de novo PNH. Age, gender and symptom distributions were similar in both groups, at diagnosis. However, when comparing these patients at presentation, anemia was less frequently, but thrombopenia and neutropenia were more frequently observed. Patients with the AA-PNH syndrome were more frequently treated initially with androgens or immimosuppressive therapy than those with de novo PNH. During follow-up, the prevalence or cumulative incidence of main complications was similar in both groups. Multivariate analysis showed that 5 factors influenced survival in both groups (thrombosis, MDS or acute leukemia, age over 54 years, thrombocytopenia at diagnosis and mitial treatment other than androgens), while 1 factor (pancytopenia durmg the evolution) increased the risk of death in patients with de novo PNH. Treatment other than androgens led to an increased risk of death (∼ 5 fold) in patients with de novo PNH while it lowered the risk of death (∼ 4 fold) in patients with the AA-PNH syndrome, compared to patients treated by androgens in either group.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Rosse, W.F. Paroxysmal nocturnal hemoglobinuria. In Principles and practice of hematology; Stossel TP & Lux SE, eds (1995): Lippincott, Philadelphia: chapter 11; pp 367–76
Socié, G., Mary, J.Y., De Gramont, A., et al (1996). Paroxysmal nocturnal hemoglobinuria: long-term follow up and prognostic factors. Lancet 348: 573–577.
Lewis, S.M. & Dacie J.V (1967). The aplastic anaemia-paroxysmal nocturnal hemoglobinuria syndrome. Br J Haematol. 13: 236–251.
Dacie, J.V. & Lewis, M (1972). Paroxysmal nocturnal haemoglobinuria: clinical manifestation, haematology, and nature of the disease. Ser Haematol. 3: 3–23.
Strubing, P (1882). Paroxysmale Haemoglobinurie. Deutsche Med Woch, 8: 1–3.
Yeh E.T.H., Rosse, W.F (1994). Paroxysmal noctumal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Inv 93: 2305–2312.
Bessler, M., Mason, P. J., Hillmen, P., et al. (1994) Paroxysmal noctumal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13: 110–117.
Takeda, J., Miyata, T., Kawagoe, et al. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal noctumal hemoglobinuria. Cell 73: 703–711.
Luzzatto, L. & Bessler, M. (1997) The dual pathogenesis of paroxysmal noctumal hemoglobinuria. Current Op Hematol 3: 101–110.
Nagarajan, S., Brodsky, R.A., Young N.S., Medof M. E. (1995) Genetic defects underlying paroxysmal noctumal hemoglobinuria that arises out of aplastic anemia. Blood 86: 4656–4661.
Dacie, J.V. & Gilpin A. (1944) Refractory anaemia (Fanconi type): its incidence in three members of one family, with in one case a relationship to chronic haemolytic anaemia with noctumal haemoglobinuria. Arch Dis Child 19: 155–162.
Dameshek, W. (1967) What do aplastic anemia, paroxysmal noctumal hemoglobinuria and “hypoplastic” leukemia have in common? Blood 30: 251–255.
Hillmen, P., Lewis, S.M., Bessler, M., Luzzatto, L., Dacie, J.V. (1995) Natural history of paroxysmal noctumal hemoglobinuria. New Engl J Med 333: 1253–1258.
Späth-Schwalbe, E., Schrezenmeier, H., Heimpel, H. (1995) Paroxysmale nätliche hämoglobinurie: Klinische erfahrungen bei 40 patienten in einem zentmm über 25 jähre. Deutsche Med Woch 120: 1027–1033.
Fujioka, S. & Takayoshi, T. (1989) Prognostic features of paroxysmal noctumal hemoglobinuria in Japan. Acta Haematol Jap 2: 1386–1394.
Tichelli, A., Gratwohl, A., Nissen, C, Speck, B. (1994) Late clonal complications in severe aplastic anemia. Leuk Lym 12: 167–175.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this paper
Cite this paper
Socié, G., Mary, JY. (2003). Clinical Pathology and natural history of PNH; The French Society of Hematology experience.. In: Omine, M., Kinoshita, T. (eds) Paroxysmal Nocturnal Hemoglobinuria and Related Disorders. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67867-0_7
Download citation
DOI: https://doi.org/10.1007/978-4-431-67867-0_7
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68004-8
Online ISBN: 978-4-431-67867-0
eBook Packages: Springer Book Archive